References
- Winograd EJ, Sollee D, Schauben JL, et al. Pediatric guanfacine exposures reported to the National Poison Data System, 2000–2016. Clin Toxicol. 2020;58(1):49–55.
- Panther SG, Knotts AM, Odom-Maryon T, et al. Off-label prescribing trends for ADHD medications in very young children. J Pediatr Pharmacol Ther. 2017;22(6):423–429.
- Black BT, Soden SE, Kearns GL, et al. Clinical and pharmacologic considerations for guanfacine use in very young children. J Child Adolesc Psychopharmacol. 2016;26(6):498–504.
- McGrath JC, Klein-Schwartz W. Epidemiology and toxicity of pediatric guanfacine exposures. Ann Pharmacother. 2002;36(11):1698–1703.
- Food and Drug Administration. Guanfacine extended-release (ER). Available from: www.fda.gov.